Back to News
Market Impact: 0.35

Benchmark reiterates DraftKings stock Buy rating, $29 target

Analyst InsightsCorporate EarningsCompany FundamentalsMarket Technicals & FlowsConsumer Demand & Retail
Benchmark reiterates DraftKings stock Buy rating, $29 target

Benchmark reiterated a Buy on DraftKings with a $29 price target versus a $26.13 share price, while InvestingPro flagged the stock as potentially undervalued despite a 27.69% six-month decline. Week 8 New York online sports betting data were mixed: DraftKings handle fell 12.5% year over year and GGR dropped 32.7% on a lower 9.2% hold, while FanDuel, PENN, Rush Street, and Fanatics posted varied handle and revenue trends. Additional analyst coverage remained constructive, with UBS at $43, Citizens at $34, and Freedom Broker at $30, reinforcing a positive but uneven sector setup.

Analysis

The key setup is not simply that DKNG is a quality name on sale; it is that the entire sportsbook cohort is moving from volume-led growth to hold-led dispersion. When handles are still expanding in pockets but GGR is decelerating, the market starts pricing operator-specific hold normalization rather than top-line beta, which favors names with scale, product breadth, and lower promo intensity. DKNG’s weakness looks less like a demand problem and more like a monetization problem, which is harder to fix quickly but also easier to re-rate if pricing discipline improves over the next 1-2 quarters.

The real second-order winner may be the market leader that can absorb hold volatility while continuing to cross-sell into iGaming and emerging products. That argues for relative-value ownership versus smaller operators whose volume growth is being purchased with margin sacrifice; Fanatics’ rapid scale with collapsing hold is the clearest warning sign that share gains are not yet translating into earnings power. PENN’s better GGR print on weaker handle suggests the street should be willing to pay for better hold economics, but that is more a statement on execution than secular share gains.

For DKNG, the near-term catalyst path is earnings and state-by-state hold normalization, not handle acceleration. If hold remains sub-10% into the next few monthly prints, consensus may have to cut revenue/Ebitda estimates despite positive analyst targets, creating another leg down over 4-8 weeks. The upside case is that the current drawdown has already discounted a prolonged low-hold regime, so any reversion toward historical hold would create operating leverage very quickly; that makes this a classic 6-12 month re-rating trade rather than a clean tactical momentum long.